TVTX Q1 2017 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+15.9% YoY

Gross Profit

$33M97.9% margin

Operating Income

-$14M-42.9% margin

Net Income

-$11M-33.0% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-9.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$7M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$510M

Total Liabilities

$209M

Stockholders' Equity

$301M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$29M	+15.9%
Gross Profit	$33M	$28M	+16.5%
Operating Income	-$14M	-$8M	-74.8%
Net Income	-$11M	$11M	-198.9%